Vascularization enhanced graft constructs

• US 7,815,686 B2
• Filed: 05/02/2003
• Issued: 10/19/2010
• Est. Priority Date: 05/02/2002
• Status: Active Grant

• Current Assignee: Clarian Health Partners, Inc.
• Original Assignee: Clarian Health Partners, Inc., Purdue Research Foundation (The Trustees of Purdue University (d/b/a Purdue University))
• Inventors: Badylak, Stephen F.
• Primary Examiner(s): SWEET, THOMAS
• Application Number:
  US10/428,350
• Publication Number:
  US 20030216811A1
• Time in Patent Office: 2,727 Days
• Field of Search: 424/93.1, 424/520, 424/550, 424/551, 623/23.72, 623/23.76
• US Class Current: 623/23.72
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system
• CPC Class Codes: C12N 2501/135 Platelet-derived growth factor [PDGF]
• CPC Class Codes: C12N 2501/15 Transforming growth factor beta (TGF-β)
• CPC Class Codes: C12N 2501/165 Vascular endothelial growth factor [VEGF]
• CPC Class Codes: C12N 2502/1347 Smooth muscle cells
• CPC Class Codes: C12N 2502/23 Gastro-intestinal tract cells
• CPC Class Codes: C12N 2502/28 Vascular endothelial cells
• CPC Class Codes: C12N 2509/00 Methods for the dissociation of cells, e.g. specific use of enzymes
• CPC Class Codes: C12N 5/069 Vascular Endothelial cells
• CPC Class Codes: C12N 5/0697 Artificial constructs associating cells of different lineages, e.g. tissue equivalents blood vessels C12N5/0691

Abstract

An intestinal submucosa tissue graft construct for use in repairing diseased or damaged tissues is provided. The graft construct comprises vertebrate intestinal submucosa tissue, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhances initiation of the formation of vessel-like structures in the graft. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these intestinal submucosa tissue graft constructs and for preparing these graft constructs are also provided.

Claims

1. A submucosa tissue graft construct, said tissue graft construct comprising vertebrate submucosa tissue, exogenously added endothelial cells, and at least one additional preselected, exogenous population of cells, wherein the tissue graft construct lacks vessels or vessel-like structures including the endothelial cells, and wherein the at least one additional preselected, exogenous population of cells is effective to enhance the initiation of formation of vessels or vessel-like structures including endothelial cells in said graft construct.

2. The graft construct of claim 1 wherein the submucosa tissue is delaminated from the tunica muscularis and at least the luminal portion of the tunica mucosa of said tissue.

3. The graft construct of claim 2 wherein the at least one additional cell population comprises a population of cells selected from the group consisting of keratinized epithelial cells, non-keratinized epithelial cells, and mesodermally derived cells.

4. The graft construct of claim 3 wherein the at least one additional preselected, exogenous population of cells is selected from keratinized and non-keratinized epithelial cells.

5. The graft construct of claim 2 wherein the at least one additional cell population comprises a population of smooth muscle cells.

6. The graft construct of claim 2 wherein the at least one additional cell population comprises a population of smooth muscle cell progenitor cells.

7. The graft construct of claim 2 wherein the submucosa tissue is seeded with the additional preselected population of cells after the submucosa tissue is seeded with the endothelial cells.

8. The graft construct of claim 1 further comprising a heparinase.

9. The graft construct of claim 1 further comprising a growth factor selected from the group consisting of vascular endothelial cell-derived growth factor, platelet-derived growth factor, a platelet-derived growth factor-like molecule, transforming growth factor β

, and a serum growth factor.

10. The graft construct of claim 1 wherein the submucosa tissue is seeded with the endothelial cells after the submucosa tissue is seeded with the additional preselected population of cells.

11. The graft construct of claim 1 wherein the submucosa tissue is seeded with the endothelial cells and the additional preselected population of cells simultaneously or nearly simultaneously.

12. The graft construct of claim 1 wherein the submucosal tissue is in fluidized form.

13. The graft construct of claim 1 wherein the submucosal tissue is in powder form.

14. The graft construct of claim 1 wherein the submucosal tissue comprises multiple layers.

15. The graft construct of claim 1 wherein the construct is in the form of a sheet.

16. A vascularized submucosa tissue graft construct for use in repairing diseased or damaged tissues, said tissue graft construct comprising vertebrate submucosa tissue, exogenously added endothelial cells, and at least one additional preselected, exogenous population of cells wherein said endothelial cells have been cultured on said submucosa tissue for a time sufficient to form vessels or vessel-like structures in vitro wherein the at least one additional preselected, exogenous population of cells enhances the initiation of formation of vessels or vessel-like structures in said graft construct that lacks vessels or vessel-like structures.

17. The graft construct of claim 16 wherein the submucosa tissue is delaminated from the tunica muscularis and at least the luminal portion of the tunica mucosa of said tissue.

18. The graft construct of claim 16 wherein the submucosal tissue is in fluidized form.

19. The graft construct of claim 16 wherein the submucosal tissue is in powder form.

20. The graft construct of claim 16 wherein the submucosal tissue comprises multiple layers.

21. A submucosa tissue graft construct having vessel-like structures for use in repairing diseased or damaged tissues, said tissue graft construct comprising vertebrate submucosa tissue, exogenously added endothelial cells, and at least one additional preselected, exogenous population of cells, wherein said endothelial cells and said additional population of cells have been cultured together on the submucosa tissue from a time at which the graft construct lacked the vessel-like structures and wherein said additional population of cells has enhanced the initiation of formation of the vessel-like structures in said graft construct.

22. The graft construct of claim 21 wherein the at least one additional cell population comprises a population cells selected from the group consisting of keratinized epithelial cells, non-keratinized epithelial cells, and mesodermally derived cells.

23. The graft construct of claim 21 wherein the at least one additional cell population comprises a population of smooth muscle cells.

24. The graft construct of claim 21 wherein the at least one additional cell population comprises a population of smooth muscle cell progenitor cells.

25. The graft construct of claim 21 further comprising a heparinase.

26. The graft construct of claim 21 further comprising a growth factor selected from the group consisting of vascular endothelial cell-derived growth factor, platelet-derived growth factor, a platelet-derived growth factor-like molecule, transforming growth factor, and a serum growth factor.

27. The graft construct of claim 21 wherein the submucosa tissue is seeded with the additional preselected population of cells after the submucosa tissue is seeded with the endothelial cells.

28. The graft construct of claim 21 wherein the submucosa tissue is seeded with the endothelial cells after the submucosa tissue is seeded with the additional preselected population of cells.

29. The graft construct of claim 21 wherein the submucosa tissue is seeded with the endothelial cells and the additional preselected population of cells simultaneously or nearly simultaneously.

30. The graft construct of claim 21 wherein the submucosa tissue is delaminated from the tunica muscularis and at least the luminal portion of the tunica mucosa of said tissue.

31. The graft construct of claim 21 wherein the submucosal tissue is in fluidized form.

32. The graft construct of claim 21 wherein the submucosal tissue is in powder form.

33. The graft construct of claim 21 wherein the submucosal tissue comprises multiple layers.